Prof. Assoc. Velizarova: We won’t be able to meet those vaccinated next winter – ᐉ News from Bulgaria • latest news and current information



[ad_1]

Even with a partial relaxation of measures, the incidence of COVID-19 will increase because the infection is transmitted by airborne droplets. This was announced on “This Sunday” on bTV by Associate Professor Svetlana Velizarova, Director of the Children’s Clinic at St. Sophia Lung Hospital.

According to her, this does not mean extending the “confinement”. He added that he believes there is a hidden morbidity that is not reported in official statistics.

“I think that around 2 million Bulgarians have already contracted the infection. This means that each subsequent wave will be weaker. We cannot be closed forever,” he said.

Associate Professor Velizarova explained that there is no evidence that the virus’s most contagious mutation, which circulates mainly in the UK, causes more severe symptoms. He added that this strain was noticed in our country in June.


“A question of the genetic predisposition of a population is the greater or lesser susceptibility of a strain. We have to open partially from the end of January, the students have to go back to class, no more. They will lose a full year,” he added.

According to the pulmonologist, all infectious diseases in a certain percentage of patients cause myocarditis, regardless of age, and COVID-19 is no exception.

“Many more children are infected by adults than adults. So far, there is no evidence that children with diabetes have a serious disease. The viral load that children carry is much lower, so they transmit the infection less”, added the expert.

Assistant Professor Velizarova noted that she was vaccinated 10 days ago and will soon receive a second dose. He explained that people are unlikely to get their second dose of the drug because it is not used for someone else but is stored. According to her, by June our country should receive 1.5 million doses of Pfizer / Biontech and Moderna, which will reach 750,000 people.

“This is not encouraging at all, because with this amount we will not be able to meet those vaccinated next autumn-winter season. AstraZeneca’s vector vaccine is currently not very accurate, with an efficacy of between 70 and 90%. “I would choose an informational RNA vaccine because it is a revolutionary achievement for humanity,” he said.



[ad_2]